Kardigan, Inc. Common Stock Market Cap ($1.32 Billion)
Market Cap & Net Worth: Kardigan, Inc. Common Stock (KARD)
Kardigan, Inc. Common Stock market cap. Kardigan, Inc. Common Stock (NASDAQ:KARD) has a market capitalization of $1.32 Billion ($1.32 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7448 globally and #2287 in its home market, demonstrating a 10.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kardigan, Inc. Common Stock's stock price $14.13 by its total outstanding shares 93503699 (93.50 Million). Also see Kardigan, Inc. Common Stock (KARD) cash conversion ratio for how efficiently the company converts equity into cash flow.
Kardigan, Inc. Common Stock Market Cap History (2026–2026)
Kardigan, Inc. Common Stock market cap history from 2026 to 2026. Data shows growth from $1.32 Billion to $1.32 Billion (0.00% CAGR). Check current stock price of Kardigan, Inc. Common Stock for real-time trading data and today's change.
Kardigan, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kardigan, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Kardigan, Inc. Common Stock (KARD) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of KARD by Market Capitalization
Companies near Kardigan, Inc. Common Stock in the global market cap rankings as of November 1, 2026. Also see Kardigan, Inc. Common Stock assets under control for a full breakdown of the balance sheet.
Key companies related to Kardigan, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Kardigan, Inc. Common Stock (2026–2026)
Market capitalization of Kardigan, Inc. Common Stock from 2026 to today. Between 2026 and today, Kardigan, Inc. Common Stock's market cap moved from $1.32 Billion to $ 1.32 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Kardigan, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.32 Billion USD |
| MoneyControl | $1.32 Billion USD |
| MarketWatch | $1.32 Billion USD |
| marketcap.company | $1.32 Billion USD |
| Reuters | $1.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kardigan, Inc. Common Stock
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI… Read more